{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:43:25Z","timestamp":1790189005919,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1124\/mol.105.019281","type":"journal-article","created":{"date-parts":[[2006,1,18]],"date-time":"2006-01-18T03:28:25Z","timestamp":1137554905000},"page":"1216-1225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Antimony-Based Antileishmanial Compounds Prolong the Cardiac Action Potential by an Increase in Cardiac Calcium Currents"],"prefix":"10.1016","volume":"69","author":[{"given":"Yuri A.","family":"Kuryshev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Wible","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckhard","family":"Ficker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.105.019281_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.bjp.0706030","article-title":"Antimony-induced cardiomyopathy in guinea-pig and protection by l-carnitine","volume":"144","author":"Alvarez","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.105.019281_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1006\/jmcc.2000.1346","article-title":"The cardiac sodium channel: gating function and molecular pharmacology","volume":"33","author":"Balser","year":"2001","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/mol.105.019281_bib3","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4314\/eamj.v78i11.8952","article-title":"Electrocardiographic findings in Ethiopians on pentavalent antimony therapy for visceral Leishmaniasis","volume":"78","author":"Berhe","year":"2001","journal-title":"East Afr Med J"},{"key":"10.1124\/mol.105.019281_bib4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4269\/ajtmh.1982.31.459","article-title":"Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro.","volume":"31","author":"Berman","year":"1982","journal-title":"Am J Trop Med Hyg"},{"key":"10.1124\/mol.105.019281_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/infdis\/142.1.83","article-title":"An in vitro model for investigation of chemotherapeutic agents in Leishmaniasis","volume":"142","author":"Berman","year":"1980","journal-title":"J Infect Dis"},{"key":"10.1124\/mol.105.019281_bib6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0022-3565(24)29515-X","article-title":"Hydrogen peroxide modifies the kinetics of HERG channel expressed in a mammalian cell line","volume":"297","author":"Berube","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.105.019281_bib7","first-page":"66","article-title":"Selective determination of antimony (III) and antimony (V) in serum and urine and total antimony in skin biopsies of patients with cutaneous leishmaniasis treated with meglumine antimoniate","volume":"10","author":"Burguera","year":"1993","journal-title":"Trace Elem Med"},{"key":"10.1124\/mol.105.019281_bib8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1469-0691.2002.00456.x","article-title":"Death from cumulative sodium stibogluconate toxicity on Kala-Azar","volume":"8","author":"Cesur","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1124\/mol.105.019281_bib9","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4269\/ajtmh.1985.34.702","article-title":"Electrocardiographic changes during treatment of Leishmaniasis with pentavalent Antimony (sodium stibogluconate)","volume":"34","author":"Chulay","year":"1985","journal-title":"Am J Trop Med Hyg"},{"key":"10.1124\/mol.105.019281_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0028-1105096","article-title":"Therapie der Bilharziose","volume":"93","author":"Doenges","year":"1968","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1124\/mol.105.019281_bib11","unstructured":"European Medicines Agency (2004) ICH S7B. The nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals. European Medicines Agency EMEA, CHMP\/ICH\/423\/02. (http:\/\/www.emea.eu.int\/pdfs\/human\/ich\/042302en.pdf)"},{"key":"10.1124\/mol.105.019281_bib12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1540-8167.2004.03534.x","article-title":"Drug-induced Torsades de Pointes and implications for drug development","volume":"15","author":"Fenichel","year":"2004","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1124\/mol.105.019281_bib13","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1161\/01.RES.0000079028.31393.15","article-title":"Role of the cytosolic chaperones Hsp70 and Hsp90 in maturation of the cardiac potassium channel HERG","volume":"92","author":"Ficker","year":"2003","journal-title":"Circ Res"},{"key":"10.1124\/mol.105.019281_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1124\/mol.66.1.33","article-title":"Mechanism of arsenic-induced prolongation of cardiac repolarization","volume":"66","author":"Ficker","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.105.019281_bib15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4269\/ajtmh.1995.52.435","article-title":"Antimony oxidation states in antileishmanial drugs","volume":"52","author":"Franco","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"10.1124\/mol.105.019281_bib16","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1128\/AAC.45.3.913-916.2001","article-title":"Glutathione-induced conversion of pentavalent antimony to trivalent antimony in meglumine antimoniate","volume":"45","author":"Frezard","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/mol.105.019281_bib17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1042\/bj0370198","article-title":"A study of the excretion of organic antimonials using a polarographic procedure","volume":"37","author":"Goodwin","year":"1943","journal-title":"Biochem J"},{"key":"10.1124\/mol.105.019281_bib18","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","article-title":"Visceral leishmaniasis: current status of control, diagnosis, and treatment and a proposed research and development agenda","volume":"2","author":"Guerin","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1124\/mol.105.019281_bib19","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"key":"10.1124\/mol.105.019281_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1016251023427","article-title":"Pharmacokinetics of antimony in patients treated with sodium stibogluconate for cutaneous leishmaniasis","volume":"12","author":"Jaser","year":"1995","journal-title":"Pharm Res (NY)"},{"key":"10.1124\/mol.105.019281_bib21","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/jpet.104.073692","article-title":"Pentamidine-induced long QT syndrome and block of hERG trafficking","volume":"312","author":"Kuryshev","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.105.019281_bib22","first-page":"1071","article-title":"Potassium antimonyl tartrate induces reactive oxygen species-related apoptosis in human myeloid leukemic HL60 cells","volume":"20","author":"Lecureur","year":"2002","journal-title":"Int J Oncol"},{"key":"10.1124\/mol.105.019281_bib23","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1073\/pnas.98.4.1643","article-title":"Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity","volume":"98","author":"Liu","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.105.019281_bib24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00216-001-1213-7","article-title":"Monitoring of total antimony and its species by ICP-MS and on-line ion chromatography in biological samples from patients treated for leishmaniasis","volume":"372","author":"Miekeley","year":"2002","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/mol.105.019281_bib25","first-page":"3893","article-title":"Mechanism of action of arsenic trioxide","volume":"62","author":"Miller","year":"2002","journal-title":"Cancer Res"},{"key":"10.1124\/mol.105.019281_bib26","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1182\/blood.V92.11.4308","article-title":"Trivalent antimonials induce degradation of the PML-RAR\u03b1 oncoprotein and reorganization of the promyelocytic leukemia nuclear bodies in acute promyelocytic leukemia NB4 cells","volume":"92","author":"Mueller","year":"1998","journal-title":"Blood"},{"key":"10.1124\/mol.105.019281_bib27","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/bmj.320.7233.490","article-title":"Tropical medicine","volume":"320","author":"Murray","year":"2000","journal-title":"BMJ"},{"key":"10.1124\/mol.105.019281_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0022-0736(97)80023-4","article-title":"Pentavalent antimonial-induced torsade de pointes","volume":"30","author":"Ortega-Carnicer","year":"1997","journal-title":"J Electrocardiol"},{"key":"10.1124\/mol.105.019281_bib29","first-page":"1255","article-title":"Pentamidine is an inhibitor of PRL phosphatases with anticancer activity","volume":"1","author":"Pathak","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/mol.105.019281_bib30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0140-6736(80)90120-8","article-title":"Renal clearance of pentavalent antimony (sodium stibogluconate)","volume":"2","author":"Rees","year":"1980","journal-title":"Lancet"},{"key":"10.1124\/mol.105.019281_bib31","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1128\/AAC.39.6.1234","article-title":"In vitro antileishmanial properties of triand pentavalent antimonial preparations","volume":"39","author":"Roberts","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/mol.105.019281_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0014-4894(66)90040-3","article-title":"Biological disposition of antibilharzial antimony drugs. II. Antimony fate and uptake by Schistosoma haematobium eggs in man","volume":"18","author":"Schulert","year":"1966","journal-title":"Exp Parasitol"},{"key":"10.1124\/mol.105.019281_bib33","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1182\/blood.V89.9.3354","article-title":"Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients","volume":"89","author":"Shen","year":"1997","journal-title":"Blood"},{"key":"10.1124\/mol.105.019281_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cell.2004.09.011","article-title":"Cav1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism","volume":"119","author":"Splawski","year":"2004","journal-title":"Cell"},{"key":"10.1124\/mol.105.019281_bib35","doi-asserted-by":"crossref","first-page":"8089","DOI":"10.1073\/pnas.0502506102","article-title":"Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations","volume":"102","author":"Splawski","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.105.019281_bib36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4269\/ajtmh.1998.59.139","article-title":"A cluster of cases of severe cardiotoxicity among Kala-Azar patients treated with a high-osmolarity lot of sodium antimony gluconate","volume":"59","author":"Sundar","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"10.1124\/mol.105.019281_bib37","doi-asserted-by":"crossref","first-page":"11698","DOI":"10.1073\/pnas.94.21.11698","article-title":"Regulation of the human ether-a-gogo related gene (HERG) K+ channels by reactive oxygen species","volume":"94","author":"Taglialatela","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.105.019281_bib38","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/S0140-6736(05)78612-8","article-title":"Sodium antimony gluconate, amphotericin and myocardial damage","volume":"351","author":"Thakur","year":"1998","journal-title":"Lancet"},{"key":"10.1124\/mol.105.019281_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/taap.1995.1006","article-title":"Antimony-induced oxidative stress and toxicity in cultured cardiac myocytes","volume":"130","author":"Tirmenstein","year":"1995","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/mol.105.019281_bib40","doi-asserted-by":"crossref","first-page":"39925","DOI":"10.1074\/jbc.M405635200","article-title":"Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani.","volume":"279","author":"Wyllie","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.019281_bib41","doi-asserted-by":"crossref","first-page":"21061","DOI":"10.1074\/jbc.273.33.21061","article-title":"HERG channel dysfunction in human long QT syndrome","volume":"273","author":"Zhou","year":"1998","journal-title":"J Biol Chem"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24067798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24067798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.105.019281","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T09:05:56Z","timestamp":1740042356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24067798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0026895X24067798"],"URL":"https:\/\/doi.org\/10.1124\/mol.105.019281","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimony-Based Antileishmanial Compounds Prolong the Cardiac Action Potential by an Increase in Cardiac Calcium Currents","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.105.019281","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}